Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
BIDU-SW
09888
5
JD HEALTH
06618
| (FY)Jun 30, 2025 | (FY)Jun 30, 2024 | (Q4)Jun 30, 2024 | (Q3)Mar 31, 2024 | (Q2)Dec 31, 2023 | (Q1)Sep 30, 2023 | (FY)Jun 30, 2023 | (Q4)Jun 30, 2023 | (Q3)Mar 31, 2023 | (Q2)Dec 31, 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total revenue | 1.80%4.63B | -9.87%4.55B | -1.28%1.23B | -10.87%988.99M | -13.77%1.16B | -13.07%1.17B | -6.96%5.04B | -6.45%1.24B | -12.87%1.11B | -10.09%1.34B |
| Cost of revenue | -2.12%3.72B | -10.32%3.8B | 2.53%1.07B | -13.36%822.5M | -14.26%956.76M | -15.76%952.07M | -7.90%4.24B | -7.83%1.05B | -13.47%949.31M | -12.35%1.12B |
| Gross profit | 21.92%903.55M | -7.49%741.09M | -21.61%153.43M | 3.85%166.5M | -11.36%200.81M | 0.86%220.35M | -1.65%801.08M | 1.67%195.73M | -9.11%160.33M | 3.03%226.54M |
| Operating expense | -0.79%798.47M | 2.85%804.85M | 4.78%198.52M | 1.92%196.59M | 1.62%208.07M | 3.21%201.68M | -4.17%782.51M | 0.75%189.47M | -5.46%192.89M | -3.30%204.75M |
| Operating profit | 264.80%105.08M | -443.45%-63.77M | -820.78%-45.09M | 7.58%-30.09M | -133.31%-7.26M | -19.04%18.68M | 1,010.99%18.57M | 40.84%6.26M | -17.86%-32.56M | 167.43%21.8M |
| Net non-operating interest income (expenses) | -26.37%-14.22M | 0.64%-11.25M | -8.34%-2.81M | 4.12%-2.56M | 11.58%-2.5M | -4.57%-3.39M | 0.01%-11.33M | 18.10%-2.59M | 4.02%-2.67M | -5.21%-2.83M |
| Non-operating interest income | 400.00%20K | 300.00%4K | 100.00%2K | 133.33%1K | --0 | 0.00%1K | -80.00%1K | 0.00%1K | -400.00%-3K | 0.00%2K |
| Non-operating interest expense | 26.51%14.24M | -0.62%11.26M | 8.38%2.81M | -3.97%2.56M | -11.64%2.5M | 4.56%3.39M | -0.04%11.33M | -18.09%2.59M | -4.17%2.67M | 5.21%2.83M |
| Net investment income | 10.77%4.41M | 11.19%3.98M | 8.76%2.06M | 0 | 14.92%624K | 13.46%1.3M | 9.51%3.58M | 7.67%1.9M | 0 | 60.18%543K |
| Gain(Loss) on financial instruments designated as cash flow hedges | ||||||||||
| Gain(Loss) on derecognition of available-for-sale financial assets | ||||||||||
| Income from associates and other participating interests | ||||||||||
| Special income (charges) | -78.47%-9.23M | 16.45%-5.17M | 159.16%3.66M | 0 | 67.70%-6.19M | 50.38%-6.19M | 0 | |||
| Less:Other special charges | 1,417.86%9.23M | ---700K | ---9.53M | --0 | ---- | ---- | ---- | ---- | ---- | ---- |
| Less:Write off | ---- | -5.14%5.87M | ---- | ---- | ---- | ---- | --6.19M | ---- | ---- | ---- |
| Other non-operating income (expenses) | -18.08%9.37M | -74.66%11.44M | -190.03%-11.63M | 82.13%15.93M | -96.89%470K | -20.51%6.67M | 13.63%45.15M | 0.85%12.91M | 45.09%8.75M | 43.11%15.1M |
| Income before tax | 247.34%95.42M | -230.09%-64.76M | -537.84%-53.8M | 36.86%-16.72M | -150.54%-17.49M | -20.80%23.26M | 374.88%49.78M | 263.55%12.29M | -8.76%-26.48M | 257.94%34.61M |
| Income tax | 2,173.52%25.33M | -95.66%1.11M | -75.45%3.21M | 37.18%-4.9M | -142.73%-4.7M | -20.21%7.5M | 112.04%25.69M | 50.20%13.09M | -9.86%-7.8M | 223.53%11M |
| Net income | 206.40%70.09M | -373.45%-65.88M | -7,000.50%-57.02M | 36.73%-11.82M | -154.18%-12.79M | -21.08%15.76M | 1,575.26%24.09M | 84.95%-803K | -8.30%-18.68M | 276.60%23.61M |
| Net income continuous operations | 206.40%70.1M | -373.45%-65.88M | -7,000.37%-57.02M | 36.73%-11.82M | -154.18%-12.79M | -21.08%15.76M | 1,575.26%24.09M | 84.95%-803K | -8.30%-18.68M | 276.60%23.61M |
| Noncontrolling interests | ||||||||||
| Net income attributable to the company | 206.40%70.09M | -373.45%-65.88M | -7,000.50%-57.02M | 36.73%-11.82M | -154.18%-12.79M | -21.08%15.76M | 1,575.26%24.09M | 84.95%-803K | -8.30%-18.68M | 276.60%23.61M |
| Preferred stock dividends | ||||||||||
| Other under preferred stock dividend | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Net income attributable to common stockholders | 206.40%70.09M | -373.45%-65.88M | -7,000.50%-57.02M | 36.73%-11.82M | -154.18%-12.79M | -21.08%15.76M | 1,575.26%24.09M | 84.95%-803K | -8.30%-18.68M | 276.60%23.61M |
| Gross dividend payment | ||||||||||
| Basic earnings per share | 206.40%99.06 | -373.42%-93.1 | -7,030.97%-80.58 | 36.70%-16.71 | -154.18%-18.08 | -21.06%22.27 | 1,574.03%34.05 | 85.01%-1.13 | -8.30%-26.4 | 276.64%33.37 |
| Diluted earnings per share | 206.40%99.06 | -373.42%-93.1 | -7,000.67%-80.58 | 36.70%-16.71 | -154.19%-18.0808 | -21.06%22.27 | 1,574.03%34.05 | 84.95%-1.1348 | -8.30%-26.4 | 276.60%33.3662 |
| Dividend per share | 0.00%37.5 | 0.00%37.5 | 0.00%37.5 | 0 | 0 | 0 | 0.00%37.5 | 0.00%37.5 | 0 | 0 |
| Currency Unit | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY |
| Accounting Standards | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP |